European recommendation for Ibrutinib and Idelalisib

[MaudMarie]

Both Ibrutinib and Idelalisib have been recommended for approval by European regulators, paving the way for formal approval in a couple of months.

Source: Reuters, 25/07/14.

Great news but more work to be done here in the UK to gain approval for the Cancer Drugs Fund and NICE.

Watch this space.

[Cllcanada Top Poster CURE Hero]

Ibrutinib and Idelalisib Coming to Europe Soon

Medscape Article

medscape.com/viewarticle/82...